Table of Contents

1 Study Coverage

• 1.1 Azithromycin Product Introduction
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Azithromycin Market Size Growth Rate by Type
  • 1.4.2 Oral
  • 1.4.3 Injectables
  • 1.4.4 Ophthalmics
• 1.5 Market by Application
  • 1.5.1 Global Azithromycin Market Size Growth Rate by Application
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Azithromycin Market Size
  • 2.1.1 Global Azithromycin Revenue 2014-2025
  • 2.1.2 Global Azithromycin Sales 2014-2025
• 2.2 Azithromycin Growth Rate by Regions
  • 2.2.1 Global Azithromycin Sales by Regions
  • 2.2.2 Global Azithromycin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Azithromycin Sales by Manufacturers
  • 3.1.1 Azithromycin Sales by Manufacturers
  • 3.1.2 Azithromycin Sales Market Share by Manufacturers
• 3.2 Azithromycin Revenue by Manufacturers
  • 3.2.1 Azithromycin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Azithromycin Revenue Share by Manufacturers (2014-2019)
• 3.3 Azithromycin Price by Manufacturers
• 3.4 Azithromycin Manufacturing Base Distribution, Product Types
  • 3.4.1 Azithromycin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Azithromycin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Azithromycin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Azithromycin Sales by Type
• 4.2 Global Azithromycin Revenue by Type
• 4.3 Azithromycin Price by Type

5 Breakdown Data by Application

• 5.1 Overview
• 5.2 Global Azithromycin Breakdown Data by Application

6 North America

• 6.1 North America Azithromycin by Country
  • 6.1.1 North America Azithromycin Sales by Country
  • 6.1.2 North America Azithromycin Revenue by Country
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Azithromycin by Type
• 6.3 North America Azithromycin by Application

7 Europe

• 7.1 Europe Azithromycin by Country
  • 7.1.1 Europe Azithromycin Sales by Country
  • 7.1.2 Europe Azithromycin Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Azithromycin by Type
• 7.3 Europe Azithromycin by Application

8 Asia Pacific

• 8.1 Asia Pacific Azithromycin by Country
  • 8.1.1 Asia Pacific Azithromycin Sales by Country
  • 8.1.2 Asia Pacific Azithromycin Revenue by Country
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Azithromycin by Type
• 8.3 Asia Pacific Azithromycin by Application

9 Central & South America

• 9.1 Central & South America Azithromycin by Country
  • 9.1.1 Central & South America Azithromycin Sales by Country
  • 9.1.2 Central & South America Azithromycin Revenue by Country
  • 9.1.3 Brazil
  • 9.1.4 Argentina
• 9.2 Central & South America Azithromycin by Type
• 9.3 Central & South America Azithromycin by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Azithromycin by Country
  • 10.1.1 Middle East and Africa Azithromycin Sales by Country
  • 10.1.2 Middle East and Africa Azithromycin Revenue by Country
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Azithromycin by Type
• 10.3 Middle East and Africa Azithromycin by Application

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Azithromycin Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Akorn
  • 11.2.1 Akorn Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Akorn Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Akorn Azithromycin Products Offered
  • 11.2.5 Akorn Recent Development
• 11.3 Teva
  • 11.3.1 Teva Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Teva Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Teva Azithromycin Products Offered
  • 11.3.5 Teva Recent Development
• 11.4 Mylan
  • 11.4.1 Mylan Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Mylan Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Mylan Azithromycin Products Offered
  • 11.4.5 Mylan Recent Development
• 11.5 Zydus Pharmaceuticals
  • 11.5.1 Zydus Pharmaceuticals Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Zydus Pharmaceuticals Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Zydus Pharmaceuticals Azithromycin Products Offered
  • 11.5.5 Zydus Pharmaceuticals Recent Development
• 11.6 Sandoz
  • 11.6.1 Sandoz Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sandoz Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sandoz Azithromycin Products Offered
  • 11.6.5 Sandoz Recent Development
• 11.7 Wockhardt
  • 11.7.1 Wockhardt Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Wockhardt Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Wockhardt Azithromycin Products Offered
  • 11.7.5 Wockhardt Recent Development
• 11.8 Gland Pharma
  • 11.8.1 Gland Pharma Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Gland Pharma Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Gland Pharma Azithromycin Products Offered
  • 11.8.5 Gland Pharma Recent Development
• 11.9 Aurobindo Pharma
  • 11.9.1 Aurobindo Pharma Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Aurobindo Pharma Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Aurobindo Pharma Azithromycin Products Offered
  • 11.9.5 Aurobindo Pharma Recent Development
• 11.10 CSPC Ouyi Pharmaceutical
  • 11.10.1 CSPC Ouyi Pharmaceutical Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 CSPC Ouyi Pharmaceutical Azithromycin Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 CSPC Ouyi Pharmaceutical Azithromycin Products Offered
  • 11.10.5 CSPC Ouyi Pharmaceutical Recent Development
• 11.11 Hainan Poly Pharm
• 11.12 Hainan Hailing Chemipharma Corporation
• 11.13 Anke Hengyi

12 Future Forecast

• 12.1 Azithromycin Market Forecast by Regions
  • 12.1.1 Global Azithromycin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Azithromycin Revenue Forecast by Regions 2019-2025
• 12.2 Azithromycin Market Forecast by Type
  • 12.2.1 Global Azithromycin Sales Forecast by Type 2019-2025
  • 12.2.2 Global Azithromycin Revenue Forecast by Type 2019-2025
• 12.3 Azithromycin Market Forecast by Application
• 12.4 North America Azithromycin Forecast
• 12.5 Europe Azithromycin Forecast
• 12.6 Asia Pacific Azithromycin Forecast
• 12.7 Central & South America Azithromycin Forecast
• 12.8 Middle East and Africa Azithromycin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Azithromycin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Azithromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler's diarrhea, and certain other intestinal infections. It may also be used for a number of sexually transmitted infections, including chlamydia and gonorrhea infections. Along with other medications, it may also be used for malaria. It can be taken by mouth or intravenously with doses once per day.
The global Azithromycin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Azithromycin market based on company, product type, end user and key regions.

This report studies the global market size of Azithromycin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Azithromycin in these regions.
This research report categorizes the global Azithromycin market by top players/brands, region, type and end user. This report also studies the global Azithromycin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Akorn
Teva
Mylan
Zydus Pharmaceuticals
Sandoz
Wockhardt
Gland Pharma
Aurobindo Pharma
CSPC Ouyi Pharmaceutical
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Anke Hengyi

Azithromycin market size by Type
Oral
Injectables
Ophthalmics
Azithromycin market size by Applications
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Azithromycin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Azithromycin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Azithromycin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Azithromycin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Azithromycin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Azithromycin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.